1. Home
  2. SIBN vs OPY Comparison

SIBN vs OPY Comparison

Compare SIBN & OPY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SIBN
  • OPY
  • Stock Information
  • Founded
  • SIBN 2008
  • OPY 1881
  • Country
  • SIBN United States
  • OPY United States
  • Employees
  • SIBN N/A
  • OPY N/A
  • Industry
  • SIBN Medical/Dental Instruments
  • OPY Investment Bankers/Brokers/Service
  • Sector
  • SIBN Health Care
  • OPY Finance
  • Exchange
  • SIBN Nasdaq
  • OPY Nasdaq
  • Market Cap
  • SIBN 733.0M
  • OPY 696.7M
  • IPO Year
  • SIBN 2018
  • OPY N/A
  • Fundamental
  • Price
  • SIBN $17.25
  • OPY $72.89
  • Analyst Decision
  • SIBN Strong Buy
  • OPY
  • Analyst Count
  • SIBN 5
  • OPY 0
  • Target Price
  • SIBN $24.40
  • OPY N/A
  • AVG Volume (30 Days)
  • SIBN 345.1K
  • OPY 49.1K
  • Earning Date
  • SIBN 08-04-2025
  • OPY 07-29-2025
  • Dividend Yield
  • SIBN N/A
  • OPY 0.98%
  • EPS Growth
  • SIBN N/A
  • OPY 84.56
  • EPS
  • SIBN N/A
  • OPY 6.74
  • Revenue
  • SIBN $176,601,000.00
  • OPY $1,358,354,000.00
  • Revenue This Year
  • SIBN $19.48
  • OPY N/A
  • Revenue Next Year
  • SIBN $16.86
  • OPY N/A
  • P/E Ratio
  • SIBN N/A
  • OPY $10.79
  • Revenue Growth
  • SIBN 22.60
  • OPY 12.80
  • 52 Week Low
  • SIBN $11.70
  • OPY $47.39
  • 52 Week High
  • SIBN $20.05
  • OPY $73.85
  • Technical
  • Relative Strength Index (RSI)
  • SIBN 46.79
  • OPY 73.83
  • Support Level
  • SIBN $16.39
  • OPY $71.16
  • Resistance Level
  • SIBN $17.82
  • OPY $73.85
  • Average True Range (ATR)
  • SIBN 0.62
  • OPY 1.58
  • MACD
  • SIBN -0.02
  • OPY 0.48
  • Stochastic Oscillator
  • SIBN 34.68
  • OPY 84.94

About SIBN SI-BONE Inc.

SI-BONE Inc is a medical device company, that develops and commercializes a proprietary minimally invasive surgical implant system in the United States and Internationally. Its products include a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products such as iFuse-3D, iFuse-TORQ and iFuse Bedrock Granite which have applications across sacroiliac joint dysfunction and fusion, adult spinal deformity and degeneration, and pelvic trauma.

About OPY Oppenheimer Holdings Inc. (DE)

Oppenheimer Holdings Inc conducts activities in the securities industry. The company is involved in retail securities brokerage, investment banking (both corporate and public finance), institutional sales and trading, market-making, research, trust services, and investment advisory and asset management services. The company has two segments: Wealth Management, and Capital Markets. IT generates maximum revenue from Wealth Management Segment which includes commissions and fee income earned on assets under management (AUM), net interest earnings on client margin loans and cash balances, fees from money market funds, custodian fees and other activities. The company generates the majority of its revenue from the Americas, with the rest from Europe, the Middle East, and Asia.

Share on Social Networks: